TAG1 Inc. and NRG PALLAS have expanded their strategic partnership to include a multi-year agreement for the supply of Radium-224, essential for the production of Lead-212 (Pb-212) generators for radiopharmaceuticals in both the US and Europe. This collaboration aims to strengthen the isotope supply chain, enhance European readiness for radiopharmaceutical development, and address the increasing demand for decentralized isotope access, particularly for alpha therapies in oncology. The agreement follows their previous partnership focused on establishing long-term production for cancer therapeutics and reflects both organizations' commitment to advancing innovative cancer treatments through improved access to medical isotopes.
Mon, 27 Oct 2025 12:02:00 GMT | PR Newswire